Article Text

Download PDFPDF
Vertical cup/disc ratio in relation to optic disc size
  1. D B BARR,
  2. D J NOLAN
  1. Tennent Institute of Ophthalmology, Gartnavel General Hospital, 1053 Great Western Road
  2. Glasgow G12 0YN

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editor,—In a recent paper,1 the vertical cup/disc ratio (CDR) in relation to optic disc size was evaluated as an aid in the identification of optic discs with glaucomatous optic neuropathy. Two methods of using the vertical CDR were assessed, one method independent of disc size and the other dependent on disc size.

    With the disc size independent method, for a group of patients with primary open angle glaucoma (POAG) and a control group, the authors calculated the vertical CDR and, based on a histogram plot of the control group, concluded that the vertical CDR is not normally distributed. An empirical cut off for the upper limit of normal was taken as the 97.5 percentile. When this test criterion (vertical CDR = 0.682) was applied to the two groups, this method yielded a sensitivity of 56.6% and specificity of 97.7% for the identification of glaucomatous optic discs. The conclusion that the vertical CDR is not normally distributed is not disputed (Chernoff-Lehmann test,2 p<0.10). However, the optimal vertical CDR may be selected rationally (rather than arbitrarily) by plotting sensitivity against (1 − specificity) to produce a receiver operator characteristics (ROC) curve (Fig 1A). The optimal test criterion is the point on the ROC curve furthest from the line of zero discrimination3; from the authors’ data, the optimal test criterion is a vertical CDR cut off of 0.587 (sensitivity 86.6%, specificity 87.5%). Having rationally selected the optimal test criterion, its value as a clinical aid is best assessed by the predictive power of a positive test (rather than by isolated sensitivity and specificity values). This predictive power (V+) is the proportion of true positives (by reference test) to total positives (true positives + false positives) and is a function not only of sensitivity and specificity but …

    View Full Text